AptarGroup’s Activ-Blister packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration (FDA) for a HIV prevention medicine. The oral solid dose drug was developed by a leading pharmaceutical company in the HIV treatment and prevention space, and represents the first FDA approval of Aptar’s Activ-Blister packaging solution and application process developed by Aptar CSP Technologies.   The system protects oral solid drug products with a 3-Ph...